Earnings Summary

Genmab A/S’s revenue jumped 85.07% since last year same period to $598.6Mn in the Q3 2018. On a quarterly growth basis, Genmab A/S has generated 17.45% jump in its revenue since last 3-months.

Genmab A/S’s net profit jumped 3253.93% since last year same period to $179.18Mn in the Q3 2018. On a quarterly growth basis, Genmab A/S has generated -31.23% fall in its net profits since last 3-months.

Genmab A/S’s net profit margin jumped 1804.21% since last year same period to 29.93% in the Q3 2018. On a quarterly growth basis, Genmab A/S has generated -41.44% fall in its net profit margins since last 3-months.

Genmab A/S’s earning per share (EPS) estimates for the current quarter stand at 0.13 - a -64.13% fall from last quarter’s estimates.

Genmab A/S’s earning per share (EPS) estimates for the current year stand at 0.13.

Genmab A/S’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2023. This indicates that the Genmab A/S has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.